The measles immunization coverage for U.S. children aged 12-23 months remains stable at 91% from 2024 to 2028 based on forecasted data. As of 2023, the coverage stood at 91%, indicating no change. This consistency suggests a lack of variation over the last two years, maintaining a consistent CAGR of 0% over the five-year period from 2024-2028.

Future trends to watch for in measles immunization coverage include:

Potential policy changes that might influence vaccination rates, such as mandatory immunization initiatives.
The impact of public health campaigns aimed at increasing awareness and reducing vaccine hesitancy.
Trends in healthcare accessibility that could affect immunization outreach and coverage.